![]() |
The level of repeat business and positive feedback from existing clients is testament to the quality of oncology drug development services Nexus Oncology consistently deliver. |
|||||
Addition of Russian Sites Ensures Patient Recruitment Targets are Met by Nexus Oncology Nexus Achieves Impressive Recruitment rates in Very Rare Tumour Indication Nexus Awarded a Programme of Phase I Studies by Existing Sponsor Nexus Oncology Expands to North America with Repeat Business Win From Existing Sponsor Nexus Oncology Successfully Executes Phase III Registration Study for Biotech Sponsor with First in Class Molecule Successful Phase I Study Leads to Award of Full Development Programme
|
||||||
xxHome xxAbout Nexus Oncology xxExecutive Management xxConsultant Medical Advisors xxBoard of Directors xxServices xxWorking with Nexus Oncology xxUseful Links xxExperience xxTherapeutic Approaches xxTumour-type Experience xxProject Experience > Case Studies xxNewsroom xxContact Nexus Oncology xxMeet Nexus Oncology xxVacancies |
||||||
![]() |
||||||
| © Nexus Oncology 2010xxIxxwebsite credits |